Prescription Drug News and Research

RSS

Senate HELP committee approves Von Eschenbach nomination to head FDA

The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)

22 Sep 2006

Many Medicare beneficiaries lack coverage in prescription drug benefit 'doughnut hole'

Eighty-eight percent of Medicare beneficiaries enrolled in stand-alone drug plans under the Medicare prescription drug benefit are in plans that do not provide coverage during the so-called "doughnut hole," according to a report released on Thursday by Democrats on the House Ways and Means Committee, the AP/Boston Globe reports.

22 Sep 2006

Prices on medications most commonly used by older people rose 4.3% in first half of 2006

Manufacturer prices for the brand-name drugs most commonly used by individuals ages 50 and older increased by an average of 6.3% during the 12-month period ending in June, according to an AARP survey released on Tuesday, the Newark Star-Ledger reports.

22 Sep 2006

Inclusion of prescription drug reimportation provision in delaying action on homeland security appropriations

Provisions that would permit U.S. residents to purchase lower-cost prescription drugs from abroad have become a "major sticking point" to settling negotiations on the House and Senate fiscal year 2007 Homeland Security appropriations bills, CongressDaily reports (CongressDaily, 9/19).

22 Sep 2006

Some Senators concerned about plan to address Medicare premium refund checks sent erroneously

Some senators have raised concerns that a plan developed by CMS Administrator Mark McClellan and Social Security Administration Commissioner Jo Anne Barnhart to address errors in the deduction of Medicare prescription drug benefit premiums from Social Security checks "might be too harsh" for low-income beneficiaries, The Hill reports.

20 Sep 2006

Thousands of prescription drug products sold in the U.S. not approved by FDA

Drugs that have not been approved by FDA make up nearly 2% of prescription drugs on the market, and some of them "might not only be ineffective but also might actually be harmful," USA Today reports.

20 Sep 2006

House panel passes bill to require electronic health records for FEHBP members

The House Government Reform Subcommittee on the Federal Workforce and Agency Organization on Wednesday passed a bill (HR 4859) that would authorize the Office of Personnel Management to require health insurers to establish two forms of electronic health records for the Federal Employee Health Benefits Program, CongressDaily reports.

18 Sep 2006

Sen. DeMint pledges to hold Von Eschenbach's FDA Commissioner nomination unless steps taken to take Mifeprex off market

Sen. Jim DeMint (R-S.C.) plans to place a hold on President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency unless "immediate steps" are taken to remove Danco Laboratories' medical abortion drug Mifeprex from the market, DeMint press secretary Wesley Denton said recently, the New York Times reports.

18 Sep 2006

Most working adults shopping for individual insurance turned down or found it too costly

Of working-age U.S. residents who sought individual health coverage in the last three years, 89% were rejected for medical reasons or felt that the available plans were unaffordable, according to a study released last week by the Commonwealth Fund, the Los Angeles Times reports.

18 Sep 2006

Oregon Prescription Drug Program would expand coverage to all uninsured residents

An initiative that will appear on the November ballot in Oregon would expand a state prescription drug program to cover all residents without drug coverage, the Oregonian reports.

18 Sep 2006

More physicians now visit web sites to find information on brand-name prescription drugs

An increased number of physicians visited Web sites that promote brand-name prescription drugs during the first six months of 2006 to seek information about dosages and side effects, according to a recent Manhattan Research study, the Newark Star-Ledger reports.

18 Sep 2006

Congressional action on Medicare physician reimbursements unlikely before election

William Hoagland, the top budget aide to Senate Majority Leader Bill Frist (R-Tenn.), on Tuesday told health insurance industry officials that Congress likely will address a scheduled 5.1% reduction in Medicare physician reimbursements this year but not until after the midterm election, CQ HealthBeat reports.

14 Sep 2006

Fewer than half of studies conducted on effect of medications on children are published

Fewer than half of studies conducted on the effects of prescription drugs in children are published in medical journals, according to a study published Wednesday in the Journal of the American Medical Association, the AP/Lexington Herald-Leader reports.

14 Sep 2006

Fewer teens using illicit drugs, but no let up with the baby boomers

According to a new survey the use of illicit drugs among teenagers has dropped for the third year in a row.

13 Sep 2006

Accutane iPledge program requirements leading to illegal online sales

The strict regulations governing the prescription and use of the acne drug isotretinoin, sold by Roche under the brand name Accutane, are affecting the drug's sale and dispensation and raising concerns about sales of the medication over the Internet, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 9/12).

13 Sep 2006

High copayments for 'specialty pharmacy' medications has little effect on use

Higher copayments have a small effect on usage of "specialty pharmacy" medications, which can cost as much as $10,000 monthly, according to a study published Tuesday in the journal Health Affairs, the Pittsburgh Post-Gazette reports.

13 Sep 2006

GRK2 protein -a potential biomarket for heart failure

A team of cardiology researchers at Thomas Jefferson University has determined that GRK2, a protein that plays an important regulatory role in heart failure, is elevated in patients with failing hearts when compared to patients with normal heart function.

12 Sep 2006

TV advertising of prescription drugs may increase visits to doctor not actual sales

TV advertising of prescription drugs may be prompting more people to visit their doctors rather than substantially increasing sales of advertised drugs, according to research led by the Medical University of South Carolina (MUSC).

12 Sep 2006

Drug ads and their influence on patients and doctors

Television ads for prescription drugs are everywhere, enticing people to ask their doctors for this drug or that one, but the effect this type of ad has on American healthcare may be more complicated than simply inducing patients to choose one brand or the other, according to a team of researchers.

12 Sep 2006

Johns Hopkins ACG team releases pharmacy-based predictive model

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed Johns Hopkins ACG Rx-PM - new predictive modeling software based on retail pharmacy claims information.

11 Sep 2006

Prescription Drug News and Research

Senate HELP committee approves Von Eschenbach nomination to head FDA

Many Medicare beneficiaries lack coverage in prescription drug benefit 'doughnut hole'

Prices on medications most commonly used by older people rose 4.3% in first half of 2006

Inclusion of prescription drug reimportation provision in delaying action on homeland security appropriations

Some Senators concerned about plan to address Medicare premium refund checks sent erroneously

Thousands of prescription drug products sold in the U.S. not approved by FDA

House panel passes bill to require electronic health records for FEHBP members

Sen. DeMint pledges to hold Von Eschenbach's FDA Commissioner nomination unless steps taken to take Mifeprex off market

Most working adults shopping for individual insurance turned down or found it too costly

Oregon Prescription Drug Program would expand coverage to all uninsured residents

More physicians now visit web sites to find information on brand-name prescription drugs

Congressional action on Medicare physician reimbursements unlikely before election

Fewer than half of studies conducted on effect of medications on children are published

Fewer teens using illicit drugs, but no let up with the baby boomers

Accutane iPledge program requirements leading to illegal online sales

High copayments for 'specialty pharmacy' medications has little effect on use

GRK2 protein -a potential biomarket for heart failure

TV advertising of prescription drugs may increase visits to doctor not actual sales

Drug ads and their influence on patients and doctors

Johns Hopkins ACG team releases pharmacy-based predictive model

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News